Novel Biotech, Before the Company Exists

Field notes

Novel Biotech is structured as a public research record rather than a company site. The page identifies one founder, two concept studies, and a long-term interest in neurodegeneration and biological aging, while explicitly denying the existence of a lab, funding, therapy, patients, or development program. Its evidence framework separates facts, hypotheses, plans, and ambitions; detailed records and source limitations are described as being retained in a private library for approved collaborators.